Sign in
4

Changes in Ownership

Beam Therapeutics Inc. Filed Acc 0000899243-21-000430

CFO sold 25,000 shares at an average $81.78 ($2,044,485)

  • CFO acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Burrell Terry-Ann · CFO

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2021-01-04 Exercise or conversion : show line 1 in the form +25,000 $13.68 $342,000 32,309 D
2021-01-04 Sale : show line 2 in the form −800 $78.05 $62,440 31,509 D
2021-01-04 Sale : show line 3 in the form −1,951 $79.21 $154,539 29,558 D
2021-01-04 Sale : show line 4 in the form −2,449 $80.25 $196,532 27,109 D
2021-01-04 Sale : show line 5 in the form −6,509 $81.26 $528,921 20,600 D
2021-01-04 Sale : show line 6 in the form −5,296 $82.44 $436,602 15,304 D
2021-01-04 Sale : show line 7 in the form −7,095 $83.15 $589,949 8,209 D
2021-01-04 Sale : show line 8 in the form −900 $83.89 $75,501 7,309 D
Open-market sales · 25,000 sh · avg $81.78 · $2,044,485

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-01-04 Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) −25,000 357,941 D
Loading xslF345X03/doc4.xml…